US

BioPharma Credit PLC (BOPCF)

BioPharma Credit PLC (BOPCF) is listed on US. As of 2026-05-22, reported market cap is $1.16B, P/E ratio is 15.06, net margin is 82.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BOPCF

Market cap

$1.16B

P/E ratio

15.06

Gross profit (TTM)

$157.75M

Net margin

82.3%

BioPharma Credit PLC (BOPCF) — FAQ

What is BioPharma Credit PLC's market cap?

BioPharma Credit PLC (BOPCF) has a reported market cap of $1.16B (data as of 2026-05-22).

What is BOPCF's P/E ratio?

The price-to-earnings (P/E) ratio for BioPharma Credit PLC (BOPCF) is 15.06 (data as of 2026-05-22).

Does BioPharma Credit PLC pay a dividend?

Dividend yield is not available in the current snapshot for BioPharma Credit PLC (BOPCF). Check the MyAverix Finance app for the latest dividend data.

What exchange is BOPCF listed on?

BOPCF is listed on US.

What is BioPharma Credit PLC's net margin?

BioPharma Credit PLC (BOPCF) reports a net margin of 82.3% (data as of 2026-05-22).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.